Cargando…

Calcified plaque harboring lipidic materials associates with no-reflow phenomenon after PCI in stable CAD

Calcified atheroma has been viewed conventionally as stable lesion which less likely increases no-reflow phenomenon. Given that lipidic materials triggers the formation of calcification, lipidic materials could exist within calcified lesion, which may cause no-reflow phenomenon after PCI. The REASSU...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosoda, Hayato, Kataoka, Yu, Nicholls, Stephen J., Puri, Rishi, Murai, Kota, Kitahara, Satoshi, Mitsui, Kentaro, Sugane, Hiroki, Sawada, Kenichiro, Iwai, Takamasa, Matama, Hideo, Honda, Satoshi, Takagi, Kensuke, Fujino, Masashi, Yoneda, Shuichi, Otsuka, Fumiyuki, Takamisawa, Itaru, Nishihira, Kensaku, Asaumi, Yasuhide, Kawai, Kazuya, Noguchi, Teruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589149/
https://www.ncbi.nlm.nih.gov/pubmed/37378706
http://dx.doi.org/10.1007/s10554-023-02905-y
Descripción
Sumario:Calcified atheroma has been viewed conventionally as stable lesion which less likely increases no-reflow phenomenon. Given that lipidic materials triggers the formation of calcification, lipidic materials could exist within calcified lesion, which may cause no-reflow phenomenon after PCI. The REASSURE-NIRS registry (NCT04864171) employed near-infrared spectroscopy and intravascular ultrasound imaging to evaluate maximum 4-mm lipid-core burden index (maxLCBI(4mm)) at target lesions containing small (maximum calcification arc < 180°: n = 272) and large calcification (maximum calcification arc ≥ 180°: n = 189) in stable CAD patients. The associations of maxLCBI(4mm) with corrected TIMI frame count (CTFC) and no-reflow phenomenon after PCI were analyzed in patients with target lesions containing small and large calcification, respectively. No-reflow phenomenon occurred in 8.0% of study population. Receiver-operating characteristics curve analyses revealed that optimal cut-off values of maxLCBI(4mm) for predicting no-reflow phenomenon were 585 at small calcification (AUC = 0.72, p < 0.001) and 679 at large calcification (AUC = 0.76, p = 0.001). Target lesions containing small calcification with maxLCBI(4mm) ≥ 585 more likely exhibited a greater CTFC (p < 0.001). In those with large calcification, 55.6% of them had maxLCBI(4mm) ≥ 400 [vs. 56.2% (small calcification), p = 0.82]. Furthermore, a higher CTFC (p < 0.001) was observed in association with maxLCBI(4mm) ≥ 679 at large calcification. On multivariable analysis, maxLCBI(4mm) at large calcification still independently predicted no-reflow phenomenon (OR = 1.60, 95%CI = 1.32–1.94, p < 0.001). MaxLCBI(4mm) at target lesions exhibiting large calcification elevated a risk of no-reflow phenomenon after PCI. Calcified plaque containing lipidic materials is not necessarily stable lesion, but could be active and high-risk one causing no-reflow phenomenon. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10554-023-02905-y.